| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,862 | 26,792 | 22,105 | 20,057 | | Cost of Revenue | 17,656 | 18,094 | 16,448 | 14,954 | | | Gross Profit | 9,206 | 8,698 | 5,657 | 5,103 | | | Operating Expenses | | Research Development | 763 | 645 | 674 | 798 | | Selling General and Administrative | 6,559 | 7,661 | 5,721 | 7,724 | | Non Recurring |
-
| (1,172) | 10,418 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,884 | 1,564 | (11,156) | (3,419) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 7 |
-
| | Earnings Before Interest And Taxes | 1,884 | 1,564 | (11,149) | (3,419) | | Interest Expense | 873 | 878 | 848 | 865 | | Income Before Tax | 1,011 | 686 | (11,997) | (4,284) | | Income Tax Expense | 384 | 62 | (3,414) | (1,628) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 627 | 624 | (8,583) | (2,656) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 627 | 624 | (8,583) | (2,656) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $627 | $624 | ($8,583) | ($2,656) |
|
0.31% Nasdaq 0.00%
Income Statement
